The main office of represented Corporate Investor is situated in the Beijing. The fund was located in Asia if to be more exact in China.
Besides them, we counted 1 critical employee of this fund in our database.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Manufacturing, Application Specific Integrated Circuit (ASIC). For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Bitmain Technologies, Cambricon, Leyue Health.
The important activity for fund was in 2018. The common things for fund are deals in the range of more than 100 millions dollars. Speaking about the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. When the investment is from CAS Investment Management the average startup value is 500 millions - 1 billion dollars. The fund is constantly included in 2-6 deals per year.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the CAS Investment Management, startups are often financed by Sequoia Capital China, QF Capital, Oriental Fortune Capital. The meaningful sponsors for the fund in investment in the same round are Yonghua Capital, Volcanics Venture, Turing - Overview. In the next rounds fund is usually obtained by Timesbole, TCL Capital, SDIC Venture Capital.
Related Funds
Funds with similar focus
Fund Name | Location |
10x Capital Management | Florida, Niceville, United States |
360networks | Seattle, United States, Washington |
Air Products and Chemicals | Kelayres, Pennsylvania, United States |
Avanta Ventures | California, Mountain View, United States |
Dain Rauscher Wessels | Minneapolis, Minnesota, United States |
Dalma Capital | Dubai, United Arab Emirates |
Dive digital GMBH | - |
Grand Yangtze Capital | China, Shanghai |
HUB612 | France, Lyon, Rhone-Alpes |
IngDan International | China, Guangdong, Shenzhen |
Innovation Valley Partners | Knoxville, Tennessee, United States |
Keystone Bank | Austin, Texas, United States |
KTB Capital | California, San Francisco, United States |
Panming Investment | China, Shanghai |
Polish Agency for Enterprise Development | Mazowieckie, Poland, Warszawa |
Shangde Heli Touzi | China, Zhejiang, Zhuji |
Taylor Farms | California, Salinas, United States |
The Big Squeeze | - |
Yongxin Xianta Luosi Qiye Guanli Zhongxin | China, Jian, Jiangxi |
Zimmerman Ventures | Milwaukee, United States, Wisconsin |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Reetoo Biotech | $15M | 18 Dec 2023 | Shenzhen, Guangdong, China | ||
Cascade | $21M | 14 Aug 2023 | Shanghai, China | ||
CAS Space | $92M | 23 Apr 2023 | Beijing, Beijing, China | ||
Zhongtiao Technology | 20 Apr 2023 | Yangpu, Hainan, China | |||
Motong Transmission | $13M | 23 Mar 2023 | Shenzhen, Guangdong, China | ||
Wansi Medical | $15M | 20 Mar 2023 | Shijingshan, Beijing, China | ||
Hejian | $170M | 01 Jun 2022 | Shanghai, Shanghai, China | ||
Xingmu | 24 Mar 2022 | Hefei, Anhui, China | |||
WeNext | $55M | 02 Dec 2021 | Shenzhen, Guangdong, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Reetoo Biotech | $15M | 18 Dec 2023 | Shenzhen, Guangdong, China | ||
Cascade | $21M | 14 Aug 2023 | Shanghai, China | ||
CAS Space | $92M | 23 Apr 2023 | Beijing, Beijing, China | ||
Zhongtiao Technology | 20 Apr 2023 | Yangpu, Hainan, China | |||
Motong Transmission | $13M | 23 Mar 2023 | Shenzhen, Guangdong, China | ||
Wansi Medical | $15M | 20 Mar 2023 | Shijingshan, Beijing, China | ||
Hejian | $170M | 01 Jun 2022 | Shanghai, Shanghai, China | ||
Xingmu | 24 Mar 2022 | Hefei, Anhui, China | |||
WeNext | $55M | 02 Dec 2021 | Shenzhen, Guangdong, China |